SUPERNUS PHARMACEUTICALS, INC. Common Stock Shares Outstanding

Quick Answer

SUPERNUS PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 57.46 million shares for the year ending 2025.

  • SUPERNUS PHARMACEUTICALS, INC. showed an increase of +3.1% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from SUPERNUS PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2011 to 2025), SUPERNUS PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 3,356.5%.
  • Historical annual values: Fiscal year 2025: 57.46 million shares | Fiscal year 2024: 55.74 million shares | Fiscal year 2023: 54.72 million shares | Fiscal year 2022: 54.25 million shares | Fiscal year 2021: 53.26 million shares | Fiscal year 2020: 52.87 million shares | Fiscal year 2019: 52.53 million shares | Fiscal year 2018: 52.32 million shares | Fiscal year 2017: 51.31 million shares | Fiscal year 2016: 49.97 million shares | Fiscal year 2015: 49.00 million shares | Fiscal year 2014: 42.97 million shares | Fiscal year 2013: 39.98 million shares | Fiscal year 2012: 30.62 million shares | Fiscal year 2011: 1.66 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: